Pain can be sub-catogarized in two “well recognized” types of Pain:
Most of Pain killer have been developed between 100 and 50 years ago. In our current era, there is a huge demand for non-addictive (non-opioid) pain treatments.
Thanks to the crossed expertise of our expert platforms, we offer a wide combination of assays to help our clients achieve their pain preclinical drug discovery goals.
We offer in vitro and in vivo assays in non-human (neuronal cultures, spinal cord slices,…) and human tissues (native human sensory neurons or iPSC-derived sensory neurons).
For more in-depth details on our capabilities, watch our short webinar below in which Bruno Buisson, President and CSO of Neuroservices-Alliance, presents the expertise of Neuroservices-Alliance platforms:
Are you currently working on a program targeting pain? Please contact us and we will gladly discuss with you how we can be a true asset to your pain preclinical drug discovery program.